Home/Nervonik/Aydin Babakhani, PhD
AB

Aydin Babakhani, PhD

CEO, Founder, and Board Member

Nervonik

Therapeutic Areas

Nervonik Pipeline

DrugIndicationPhase
Novel PNS SystemChronic PainFirst-in-Human Completed